Erythema migrans+1
Not recruitingStudy on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment
Study on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment
- Disease:Erythema migransAntibiotic therapy
- Substances:AmoxicillinSaccharomyces boulardii CNCM I-745 lyophilized
Slovakia- Participants:18–64 years · 65+ years
- Substances:Amoxicillin
- Sponsor:Biocodex















